Clinical study on the protective mechanism of Fuling Sini Decoction in treating patients with sepsis myocardial depression under the guidance of Fuyang theory

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ITMCTR

Registry ID

ITMCTR2100005027

Enrollment

Unknown

Registered

2021-07-06

Start date

2021-07-01

Completion date

Unknown

Last updated

2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sepsis

Interventions

Treatment group:Combined with traditional Chinese medicine decoction

Control group:Western medicine routine treatment

Eligibility

Sex/Gender

All

Age

18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1.Meet the diagnostic criteria for sepsis myocardial depression; 2.Patients aged 18 to 80 years and have signed an informed consent.

Exclusion criteria

Exclusion criteria: 1.Exclude women who are pregnant or breastfeeding; 2.Exclude patients with HIV infection, rheumatic immune diseases and end-stage tumors; 3.Exclude patients with severe cardiology diseases such as myocarditis, infective endocarditis in the acute stage, or acute myocardial infarction.

Design outcomes

Primary

Measure	Time frame
Non-invasive hemodynamic monitoring index;Cardiac Color Doppler Related Index;Myocardial injury markers;Routine evaluation index of sepsis(procalcitonin\interleukin-6\C-reaction protein);	—

Countries

China

Contacts

Public ContactHuang Yonglian

Beijing University of Chinese Medicine Shenzhen Hospital (Longgang)

310184437@qq.com+86 13510540133

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026